MiMedx Group Inc  

(Public, NASDAQ:MDXG)   Watch this stock  
-0.11 (-1.62%)
Real-time:   10:01AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.58 - 6.85
52 week 1.81 - 8.80
Open 6.73
Vol / Avg. 36,695.00/826,212.00
Mkt cap 705.40M
P/E     -
Div/yield     -
EPS -0.03
Shares 105.92M
Beta 0.36
Inst. own 35%
Jul 29, 2014
Q2 2014 MiMedx Group Inc Earnings Release Add to calendar
Jun 3, 2014
MIMEDX GROUP INC at Jefferies Global Healthcare Conference - Webcast
May 28, 2014
MIMEDX GROUP INC at Craig-Hallum Institutional Investor Conference
Apr 25, 2014
Q1 2014 MIMEDX GROUP INC Earnings Conference Call - Webcast
Apr 25, 2014
Q1 2014 MIMEDX GROUP INC Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -4.71% -6.95%
Operating margin -4.56% -4.46%
EBITD margin - -0.98%
Return on average assets -4.30% -6.86%
Return on average equity -4.94% -8.79%
Employees 222 -
CDP Score - -


1775 West Oak Commons Ct. NE
United States - Map
+1-888-5431917 (Phone)
+1-678-3846720 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


MiMedx Group, Inc. (MiMedx) is an integrated developer, manufacturer and marketer of regenerative biomaterial products processed from human amniotic membrane. The Company�s biomaterial platform technologies include the device technologies HydroFix and CollaFix, and tissue technologies, AmnioFix and EpiFix. Its tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through the Company�s donor program, mothers delivering full-term caesarian births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. MiMedx processes the human amniotic membrane utilizing its Purion Process to produce a manipulated implant for homologous use. MiMedx is the supplier of amniotic tissue, having supplied over 100,000 implants to distributors and other equipment manufacturers (OEMs) for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

Officers and directors

Parker H. Petit Jr Chairman of the Board, Chief Executive Officer
Age: 73
Bio & Compensation  - Reuters
William Charles Taylor President, Chief Operating Officer, Director
Age: 44
Bio & Compensation  - Reuters
Michael J. Senken Chief Financial Officer
Age: 54
Bio & Compensation  - Reuters
Roberta L. McCaw General Counsel, Secretary
Age: 57
Bio & Compensation  - Reuters
Charles E. Koob Director
Age: 68
Bio & Compensation  - Reuters
Joseph G. Bleser Independent Director
Age: 67
Bio & Compensation  - Reuters
J. T. Dewberry Independent Director
Age: 62
Bio & Compensation  - Reuters
Charles R. Evans Independent Director
Age: 66
Bio & Compensation  - Reuters
Bruce L. Hack Independent Director
Bio & Compensation  - Reuters